Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-25-062257
Filing Date
2025-06-25
Accepted
2025-06-24 21:06:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 tm2518833d1_425.htm 425 24118
2 GRAPHIC tm2518833d1_425-img01.jpg GRAPHIC 115766
3 GRAPHIC tm2518833d1_425-img02.jpg GRAPHIC 287556
  Complete submission text file 0001104659-25-062257.txt   582032
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filed by) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36296 | Film No.: 251070701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)